Anastasios Karamiditris

12PUBLICATIONS
70CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Haematological tumoursHaematologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 13, 2026
Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers.

|Sep 02, 2026
CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

|Sep 03, 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Hongwei Ren, Natalina Elliott, Bryan Lye

|Jul 01, 2025
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia.

Maria Rosa Lidonnici, Giulia Chianella, Nicole Mende

|May 24, 2023
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.

Alexia Katsarou, Nikolaos Trasanidis, Kanagaraju Ponnusamy

|Jan 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Nikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy

Pageof 2

Frequent Collaborators

6 joint publications

Aristeidis Chaidos

3 joint publications

Holger W Auner

2 joint publications

Anindita Roy

2 joint publications

Valentina S Caputo